Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Eur Radiol
    November 2025
  1. YOSHIZAWA E, Yamada A, Okajima Y, Notake T, et al
    Harmonization of quantitative liver function evaluation using gadoxetate disodium-enhanced magnetic resonance imaging.
    Eur Radiol. 2025;35:7372-7381.
    >> Share

    October 2025
  2. OCAL O, Zech CJ, Bali MA, Pasquier D, et al
    Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR.
    Eur Radiol. 2025 Oct 31. doi: 10.1007/s00330-025-12045.
    >> Share

  3. SHI D, Kou Q, Chen HY, Chen JY, et al
    Quantitative analysis of enhanced CT in predicting microvascular invasion and pathological grading of hepatocellular carcinoma.
    Eur Radiol. 2025 Oct 31. doi: 10.1007/s00330-025-12087.
    >> Share

  4. JIA X, Jiang H, Ye Z, Wei H, et al
    Imaging for molecular and pathological subtyping of hepatocellular carcinoma-a critical appraisal and future directions.
    Eur Radiol. 2025 Oct 30. doi: 10.1007/s00330-025-12075.
    >> Share

  5. KIM YY, Chang W, Lee JM, Kim SW, et al
    Hepatocellular carcinoma risk stratification to identify patients suitable for intensive surveillance in viral hepatitis: the SELECT score.
    Eur Radiol. 2025 Oct 25. doi: 10.1007/s00330-025-12060.
    >> Share

  6. CHIU SH, Kamaya A, Tse JR
    Letter to the Editor: Early post-treatment imaging enables timely diagnosis of viable hepatocellular carcinomas after selective internal radiation therapy.
    Eur Radiol. 2025 Oct 17. doi: 10.1007/s00330-025-11998.
    >> Share

  7. WEI H, Jiang H, Lee JM
    Reply to the Letter to the Editor: Early post-treatment imaging enables timely diagnosis of viable hepatocellular carcinomas after selective internal radiation therapy.
    Eur Radiol. 2025 Oct 17. doi: 10.1007/s00330-025-11999.
    >> Share

  8. WANG Z, Liang Q, Luo J, Liao Y, et al
    Detection of macrotrabecular-massive hepatocellular carcinoma based on viscoelastic characteristics obtained by multifrequency magnetic-resonance elastography.
    Eur Radiol. 2025 Oct 9. doi: 10.1007/s00330-025-12024.
    >> Share

  9. LEE DH, Lee JM
    Toward personalized hepatocellular carcinoma treatment using liver MRI: predicting intratumoral tertiary lymphoid structure maturity.
    Eur Radiol. 2025 Oct 7. doi: 10.1007/s00330-025-11992.
    >> Share

  10. PARK JH, Goh MJ, Sinn DH, Shin J, et al
    Predicting early progression to atezolizumab-bevacizumab in hepatocellular carcinoma: a clinical and imaging-based scoring system.
    Eur Radiol. 2025 Oct 4. doi: 10.1007/s00330-025-12040.
    >> Share

  11. XU M, Yin S, Zhao Q, Tian G, et al
    Recurrence patterns and survival outcomes after irreversible electroporation for hepatocellular carcinoma: a 6-year multicenter experience.
    Eur Radiol. 2025 Oct 3. doi: 10.1007/s00330-025-12044.
    >> Share

  12. CAI W, Zhu Y, Li D, Wang B, et al
    Intratumoral heterogeneity of CT enhancement for component prediction and prognostic significance in combined hepatocellular carcinoma?cholangiocarcinoma.
    Eur Radiol. 2025 Oct 2. doi: 10.1007/s00330-025-12034.
    >> Share

  13. NJOLSTAD TH, Jensen K, Andersen HK, Berstad AE, et al
    Deep learning reconstruction for detection of liver lesions at standard-dose and reduced-dose abdominal CT.
    Eur Radiol. 2025;35:6140-6149.
    >> Share

  14. DIOGUARDI BURGIO M, Ronot M, Vilgrain V
    ESR Essentials: assessing the radiological response of liver metastases to systemic therapy-practice recommendations by the European Society of Gastrointestinal and Abdominal Radiology.
    Eur Radiol. 2025;35:6516-6526.
    >> Share

  15. MATHUR A, Ozkaya E, Rosberger S, Sigel KM, et al
    Concordance of vibration-controlled transient elastography and magnetic resonance elastography for fibrosis staging in patients with metabolic dysfunction-associated steatotic liver disease.
    Eur Radiol. 2025;35:6507-6515.
    >> Share

    September 2025
  16. GANDON Y, Chau THT, Borde P, Bannier E, et al
    Comparison of hepatic iron quantification by MRI between 1.5 and 3 T, using different methods and conversion formulas.
    Eur Radiol. 2025 Sep 27. doi: 10.1007/s00330-025-12027.
    >> Share

  17. CHEN H, Zhu J, Zhou J, Yin Z, et al
    Correction: MR elastography-based prediction of development of hepatocellular carcinoma in patients with chronic hepatitis B with sustained virological response.
    Eur Radiol. 2025 Sep 22. doi: 10.1007/s00330-025-12012.
    >> Share

  18. YAMAMOTO A, Sato S, Ueda D, Walston SL, et al
    Deep-learning-based prediction of significant portal hypertension with single cross-sectional non-enhanced CT.
    Eur Radiol. 2025 Sep 22. doi: 10.1007/s00330-025-12010.
    >> Share

  19. TAO Y, Song M, Zhang H, He H, et al
    Large well-differentiated hepatocellular carcinoma in patients with HBV: gadoxetic acid-enhanced MR imaging features and prognosis.
    Eur Radiol. 2025 Sep 12. doi: 10.1007/s00330-025-11994.
    >> Share

  20. LUDEMANN WM, Kahn J, Pustelnik D, Hardt J, et al
    Correction: Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
    Eur Radiol. 2025 Sep 11. doi: 10.1007/s00330-025-11907.
    >> Share

  21. LEWIN M, Aldhaheri R, Beaufrere A, Desterke C, et al
    Imaging features of recently identified low-grade vascular neoplasia of the liver: hepatic small vessel neoplasm and anastomosing hemangioma.
    Eur Radiol. 2025 Sep 4. doi: 10.1007/s00330-025-11915.
    >> Share

  22. MINAMIGUCHI K, Maki H, Haddad A, Cortes AC, et al
    Synthetic tumor extracellular volume as a predictive biomarker for colorectal liver metastasis patients prior to curative hepatectomy.
    Eur Radiol. 2025;35:5348-5359.
    >> Share

    August 2025
  23. CHOI SJ, Kim HY, Lee SJ, Kim SY, et al
    Value of enhancing capsule for diagnosing hepatocellular carcinoma on MRI: implications for simplifying LI-RADS.
    Eur Radiol. 2025 Aug 22. doi: 10.1007/s00330-025-11938.
    >> Share

  24. MA W, Huang X, Feng Z, Tan W, et al
    A novel multi-parameter MRI-based model for identification of high-risk metabolic dysfunction-associated steatohepatitis.
    Eur Radiol. 2025 Aug 21. doi: 10.1007/s00330-025-11944.
    >> Share

  25. LIU Z, Chen H, Yang S, Zhang R, et al
    Preoperative prediction model of microvascular invasion in intrahepatic cholangiocarcinoma patients based on CT radiomics can assist clinical surgical decision-making: a multicenter study.
    Eur Radiol. 2025 Aug 14. doi: 10.1007/s00330-025-11900.
    >> Share

  26. CHE F, Li Q, Ren W, Tang H, et al
    3D fractal dimension analysis of CT imaging for microvascular invasion prediction in hepatocellular carcinoma.
    Eur Radiol. 2025 Aug 7. doi: 10.1007/s00330-025-11878.
    >> Share

  27. LI Y, Chen Y, Wu Z, Shi Y, et al
    Noninvasive MRI imaging feature-based prediction of intratumoral tertiary lymphoid structure maturity in hepatocellular carcinoma: a multicenter retrospective study.
    Eur Radiol. 2025 Aug 6. doi: 10.1007/s00330-025-11902.
    >> Share

  28. YUAN T, Zhong T, Song J
    Vascular penetration sign: dual-phase enhanced CT manifestations of atypical liver abscess caused by Klebsiella pneumoniae.
    Eur Radiol. 2025;35:4685-4691.
    >> Share

  29. KIM SU, Hwang JA, Han S, Lee JH, et al
    Refining imaging criteria for mucinous cystic neoplasm of the liver: simplified diagnostic approach.
    Eur Radiol. 2025;35:4993-5003.
    >> Share

    July 2025
  30. ZHANG G, Li M, Feng H, Ren Y, et al
    Hepatocyte uptake ratio derived from T1 mapping for quantitative assessment of liver fibrosis.
    Eur Radiol. 2025 Jul 30. doi: 10.1007/s00330-025-11842.
    >> Share

  31. CHOI JW, Suh M, Choi Y, Lee M, et al
    Yttrium-90 glass microsphere radioembolization as frontline treatment for hepatocellular carcinoma with localized portal vein invasion.
    Eur Radiol. 2025 Jul 26. doi: 10.1007/s00330-025-11882.
    >> Share

  32. GWON DI, Kim GH, Chu HH, Kim J, et al
    Long-term outcomes of plug-assisted retrograde transvenous obliteration (PARTO) for refractory hepatic encephalopathy.
    Eur Radiol. 2025 Jul 16. doi: 10.1007/s00330-025-11831.
    >> Share

  33. BANE O, Geahchan A, Stocker D, Pavuluri S, et al
    Splanchnic hemodynamic parameters measured with 4D flow MRI can diagnose severe portal hypertension.
    Eur Radiol. 2025 Jul 15. doi: 10.1007/s00330-025-11799.
    >> Share

  34. HE X, Shi F, Cui Y, Liu J, et al
    Differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma with MRI and tumor markers: a multi-center study.
    Eur Radiol. 2025 Jul 2. doi: 10.1007/s00330-025-11780.
    >> Share

  35. ALI R, Li H, Zhang H, Pan W, et al
    Multi-site, multi-vendor development and validation of a deep learning model for liver stiffness prediction using abdominal biparametric MRI.
    Eur Radiol. 2025;35:4362-4373.
    >> Share

    June 2025
  36. HAMADOUCHE M, Vilgrain V, Hobeika C, Castera L, et al
    Ultrasound hepatorenal index for the diagnosis of steatosis in patients with type 2 diabetes: a prospective validation study.
    Eur Radiol. 2025 Jun 25. doi: 10.1007/s00330-025-11774.
    >> Share

  37. CHEN H, Zhu J, Zhou J, Yin Z, et al
    MR elastography-based prediction of development of hepatocellular carcinoma in patients with chronic hepatitis B with sustained virological response.
    Eur Radiol. 2025 Jun 12. doi: 10.1007/s00330-025-11726.
    >> Share

  38. GRIGORIADIS A, Bergquist A, Kartalis N
    Shading light in the black box of hepatobiliary imaging.
    Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11740.
    >> Share

  39. PARK R, Kim DH, Choi SH, Kim J, et al
    Preoperative scoring system for predicting microvascular invasion in intrahepatic cholangiocarcinoma using gadoxetate-enhanced MRI.
    Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11722.
    >> Share

  40. ERLEY J, Naimi L, Molwitz I, Aydemir DG, et al
    Novel insights into cardiac structure, function, perfusion, and tissue characteristics in liver cirrhosis: a magnetic resonance analysis.
    Eur Radiol. 2025 Jun 5. doi: 10.1007/s00330-025-11710.
    >> Share

  41. JIANG H, Li B, Zheng T, Qin Y, et al
    MRI-based prediction of microvascular invasion/high tumor grade and adjuvant therapy benefit for solitary HCC
    Eur Radiol. 2025;35:3223-3237.
    >> Share

  42. JENSEN CT, Wong VK, Likhari GS, Daoud TE, et al
    Dual-energy CT for differentiation of hypodense liver lesions in pancreatic adenocarcinoma.
    Eur Radiol. 2025;35:3538-3546.
    >> Share

  43. EL HOMSI M, Bou Ayache J, Fernandes MC, Horvat N, et al
    Comparison of abbreviated and complete MRI protocols for treatment response assessment of colorectal liver metastases.
    Eur Radiol. 2025;35:3450-3459.
    >> Share

  44. IMAJO K, Saigusa Y, Kobayashi T, Nagai K, et al
    Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH.
    Eur Radiol. 2025;35:3599-3609.
    >> Share

  45. JING HH, Hao D, Liu XJ, Cui MJ, et al
    Development and validation of a radiopathomics model for predicting liver metastases of colorectal cancer.
    Eur Radiol. 2025;35:3409-3417.
    >> Share

  46. LI J, Li Y, Chen YY, Wang XY, et al
    Predicting post-hepatectomy liver failure with T1 mapping-based whole-liver histogram analysis on gadoxetic acid-enhanced MRI: comparison with the indocyanine green clearance test and albumin-bilirubin scoring system.
    Eur Radiol. 2025;35:3587-3598.
    >> Share

  47. KOBAYASHI T, Kozaka K, Matsubara T, Yokka A, et al
    Super delayed phase imaging in gadoxetic acid-enhanced MRI: investigating factors contributing to improved liver contrast.
    Eur Radiol. 2025;35:3195-3205.
    >> Share

  48. TIE J, Yuan X, Liu Z, Gou X, et al
    Transjugular mesenteric-caval shunt for portal vein cavernous transformation with recurrent variceal bleeding: preliminary results.
    Eur Radiol. 2025;35:3256-3261.
    >> Share

    May 2025
  49. OCAL O, Zech CJ, Bali MA, Pasquier D, et al
    Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR.
    Eur Radiol. 2025 May 23. doi: 10.1007/s00330-025-11699.
    >> Share

  50. WEI H, Jiang H, Yoo J, Kim JH, et al
    Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma.
    Eur Radiol. 2025 May 17. doi: 10.1007/s00330-025-11659.
    >> Share

  51. ELBANNA KY, Khalili K, AlMoharb M, Goel A, et al
    Qualitative and quantitative assessment of gadoxetic acid MRI in distinguishing atypical focal nodular hyperplasia from hepatocellular adenoma subtypes.
    Eur Radiol. 2025 May 14. doi: 10.1007/s00330-025-11679.
    >> Share

  52. VERDAN S, Torri GB, Marcos VN, Moreira MHS, et al
    Ultrasound-derived fat fraction for diagnosing hepatic steatosis: a systematic review and meta-analysis.
    Eur Radiol. 2025 May 9. doi: 10.1007/s00330-025-11652.
    >> Share

  53. WU Y, Ye Z, Yang T, Yao S, et al
    Preoperative prediction of early recurrence in hepatocellular carcinoma using simultaneous multislice diffusion kurtosis imaging.
    Eur Radiol. 2025 May 6. doi: 10.1007/s00330-025-11633.
    >> Share

  54. RUAN J, He Y, Li Q, Song M, et al
    CT feature of irregular extensive ulceration as a predictor of liver metastasis in gastric gastrointestinal stromal tumours.
    Eur Radiol. 2025;35:2759-2768.
    >> Share

  55. ALVES VPV, Mouzaki M, Xanthakos SA, Zhang B, et al
    Longitudinal evaluation of pediatric and young adult metabolic dysfunction-associated steatotic liver disease defined by MR elastography.
    Eur Radiol. 2025;35:2474-2486.
    >> Share

    April 2025
  56. MU M, Cao Y, Chen Z, Fu X, et al
    Inferior vena cava-splenic vein shunt for the treatment of complete portal trunk occlusion and portal cavernoma in liver cirrhosis.
    Eur Radiol. 2025 Apr 17. doi: 10.1007/s00330-025-11571.
    >> Share

  57. SONG W, Xu Y, Zhou J, Yu J, et al
    Predicting postresection outcomes in solitary small hepatocellular carcinoma via pretreatment MR imaging features: subgroup analysis according to alpha-fetoprotein expression.
    Eur Radiol. 2025 Apr 11. doi: 10.1007/s00330-025-11558.
    >> Share

  58. ZHANG Y, Zhang Z, Yin X, Xu A, et al
    Hepatic arterial infusion chemotherapy versus transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
    Eur Radiol. 2025 Apr 11. doi: 10.1007/s00330-025-11557.
    >> Share

  59. CANNELLA R, Agnello F, Porrello G, Spinello AU, et al
    Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease.
    Eur Radiol. 2025;35:2339-2350.
    >> Share

  60. REITHMEIER B, Laun FB, Fuhres T, Uder M, et al
    Relevance of lesion size in navigator-triggered and free-breathing diffusion-weighted liver MRI.
    Eur Radiol. 2025;35:2106-2115.
    >> Share

  61. ZHANG Y, Huang C, Meng F, Hu X, et al
    Non-invasive assessment of esophageal and fundic varices in patients with primary biliary cholangitis.
    Eur Radiol. 2025;35:2330-2338.
    >> Share

    March 2025
  62. GWON DI, Chu HH, Kim GH, Kim J, et al
    Conventional transcatheter arterial chemoembolization with gelatin spheres for hepatocellular carcinoma: comparison with nonspherical gelatin sponge particles.
    Eur Radiol. 2025 Mar 27. doi: 10.1007/s00330-025-11527.
    >> Share

  63. YANG HK, Lee S, Lee MY, Kim MJ, et al
    Effectiveness of noncontrast-abbreviated magnetic resonance imaging in a real-world hepatocellular carcinoma surveillance.
    Eur Radiol. 2025 Mar 20. doi: 10.1007/s00330-025-11517.
    >> Share

  64. NAGAYAMA Y, Hokamura M, Taguchi N, Yokota Y, et al
    Liver function estimation using multiphase hepatic CT: diagnostic performance of iodine-uptake and volumetric parameters.
    Eur Radiol. 2025 Mar 13. doi: 10.1007/s00330-025-11497.
    >> Share

  65. SABORIDO B, Darnell A, Forner A, Garcia-Criado A, et al
    Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patients.
    Eur Radiol. 2025 Mar 7. doi: 10.1007/s00330-025-11495.
    >> Share

  66. OTA T, Onishi H, Fukui H, Tsuboyama T, et al
    Prediction models for differentiating benign from malignant liver lesions based on multiparametric dual-energy non-contrast CT.
    Eur Radiol. 2025;35:1361-1377.
    >> Share

    February 2025
  67. ZHANG L, Xiao Y, Dong M, Li M, et al
    Three-dimensional MR elastography-based stiffness for assessing the status of Ki67 proliferation index and Cytokeratin-19 in hepatocellular carcinoma.
    Eur Radiol. 2025 Feb 18. doi: 10.1007/s00330-025-11375.
    >> Share

  68. HEO S, Jeong B, Lee SS, Kim M, et al
    CT-based detection of clinically significant portal hypertension predicts post-hepatectomy outcomes in hepatocellular carcinoma.
    Eur Radiol. 2025 Feb 14. doi: 10.1007/s00330-025-11411.
    >> Share

  69. KIM DH, Choi SH, Koo B, Choi SJ, et al
    Effect of combining serum alpha-fetoprotein with LI-RADS v2018 on gadoxetate-enhanced MRI in the diagnosis and prognostication of hepatocellular carcinoma.
    Eur Radiol. 2025 Feb 10. doi: 10.1007/s00330-025-11418.
    >> Share

  70. LAIMER G, Verdonschot KHM, Kopf L, van der Lei S, et al
    Multicenter and inter-software evaluation of ablative margins after thermal ablation of colorectal liver metastases.
    Eur Radiol. 2025;35:1046-1056.
    >> Share

    January 2025
  71. XU H, Wang H, Yu SZ, Li XM, et al
    Prognostic and diagnostic value of [(18)F]FDG, (11)C-acetate, and [(68)Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma.
    Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-025-11352.
    >> Share

  72. ZHAO Y, Becce F, Balmer R, do Amaral RH, et al
    Prognostic value of CT-based skeletal muscle and adipose tissue mass and quality parameters in patients with liver metastases and intrahepatic cholangiocarcinoma undergoing Yttrium-90 radioembolization.
    Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-025-11349.
    >> Share

  73. ZHOU T, Han X, Xiao C, Lei X, et al
    Diagnostic accuracy of preoperative MRI in assessing macrotrabecular-massive subtype of hepatocellular carcinoma: a systematic review and meta-analysis.
    Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-024-11344.
    >> Share

  74. MALTHIERY C, Hossu G, Ayav A, Laurent V, et al
    Characterization of hepatocellular carcinoma with CT with deep learning reconstruction compared with iterative reconstruction and 3-Tesla MRI.
    Eur Radiol. 2025 Jan 8. doi: 10.1007/s00330-024-11314.
    >> Share

  75. WEI H, Zheng T, Zhang X, Zheng C, et al
    Deep learning-based 3D quantitative total tumor burden predicts early recurrence of BCLC A and B HCC after resection.
    Eur Radiol. 2025;35:127-139.
    >> Share

    December 2024
  76. ZHAO H, Zhang X, Huang B, Shi X, et al
    Application of machine learning methods for predicting esophageal variceal bleeding in patients with cirrhosis.
    Eur Radiol. 2024 Dec 21. doi: 10.1007/s00330-024-11311.
    >> Share

  77. DUPUIS M, Dupont A, Pizza S, Vilgrain V, et al
    Prognostic value of early response in predicting survival in hepatocellular carcinoma patients treated with selective internal radiation therapy.
    Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11253.
    >> Share

  78. COLLETTINI F, Andrasina T, Reimer P, Schima W, et al
    Degradable starch microspheres transarterial chemoembolization (DSM-TACE) in patients with unresectable hepatocellular carcinoma: results from the Prospective Multicenter Observational HepaStar Trial.
    Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11272.
    >> Share

  79. SHENG R, Zheng B, Zhang Y, Sun W, et al
    MRI-based microvascular invasion prediction in mass-forming intrahepatic cholangiocarcinoma: survival and therapeutic benefit.
    Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11296.
    >> Share

  80. ZHANG W, Li N, Li J, Zhao Y, et al
    Noninvasive identification of proliferative hepatocellular carcinoma on multiphase dynamic CT: quantitative and LI-RADS lexicon-based evaluation.
    Eur Radiol. 2024 Dec 12. doi: 10.1007/s00330-024-11247.
    >> Share

  81. LI Y, Li X, Xiao X, Cheng J, et al
    A novel hybrid model for predicting tertiary lymphoid structures and targeted immunotherapy outcomes in hepatocellular carcinoma: a multicenter retrospective study.
    Eur Radiol. 2024 Dec 10. doi: 10.1007/s00330-024-11255.
    >> Share

    November 2024
  82. HU Q, Li G, Zhang D, Jiang Y, et al
    Assessment of four-dimensional flow MRI for prediction of varices risk in cirrhotic patients.
    Eur Radiol. 2024 Nov 27. doi: 10.1007/s00330-024-11222.
    >> Share

  83. ZHANG L, Mai X, Li B, Li H, et al
    Fat fraction quantification by MRI predicts diagnosis and prognosis of HBV-related steatohepatitic hepatocellular carcinoma.
    Eur Radiol. 2024 Nov 22. doi: 10.1007/s00330-024-11151.
    >> Share

  84. PATEL RK, Tripathy T, Chandel K, Marri UK, et al
    Left-sided portal hypertension: what an interventional radiologist can offer?
    Eur Radiol. 2024 Nov 19. doi: 10.1007/s00330-024-11196.
    >> Share

  85. WANG Y, Mao S, Huang R, Li S, et al
    MRI findings of newly present benign focal hepatic observations following chemotherapy: distinct features in early- and late-term follow-up.
    Eur Radiol. 2024 Nov 12. doi: 10.1007/s00330-024-11185.
    >> Share

  86. JEONG B, Heo S, Lee SS, Kim SO, et al
    Predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma: nomograms based on deep learning analysis of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2024 Nov 12. doi: 10.1007/s00330-024-11173.
    >> Share

  87. LEE S, Kim YY, Shin J, Shin H, et al
    Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis.
    Eur Radiol. 2024;34:7025-7040.
    >> Share

  88. EDIN C, Ekstedt M, Karlsson M, Wegmann B, et al
    Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis.
    Eur Radiol. 2024;34:7492-7502.
    >> Share

    October 2024
  89. QI R, Lu L, He T, Zhang L, et al
    Comparing ultrasound-derived fat fraction and MRI-PDFF for quantifying hepatic steatosis: a real-world prospective study.
    Eur Radiol. 2024 Oct 16. doi: 10.1007/s00330-024-11119.
    >> Share

  90. YAN Y, Yang L
    Reply to Letter to the Editor: "Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease".
    Eur Radiol. 2024;34:6955-6956.
    >> Share

  91. JIANG C, Feng Q
    Letter to the Editor: "Liver stiffness by two?dimensional shear wave elastography for screening high?risk varices in patients with compensated advanced chronic liver disease".
    Eur Radiol. 2024;34:6953-6954.
    >> Share

  92. WEI H, Yoon JH, Jeon SK, Choi JW, et al
    Enhancing gadoxetic acid-enhanced liver MRI: a synergistic approach with deep learning CAIPIRINHA-VIBE and optimized fat suppression techniques.
    Eur Radiol. 2024;34:6712-6725.
    >> Share

    September 2024
  93. NAKAZAWA Y, Okada M, Tago K, Kuwabara N, et al
    MR elastography vs a combination of common non-invasive tests for estimation of severe liver fibrosis in patients with hepatobiliary tumors.
    Eur Radiol. 2024 Sep 30. doi: 10.1007/s00330-024-11086.
    >> Share

  94. GU K, Min JH
    Reply to Letter to the Editor: "Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection" from Xiaoping Yu, MD; Huaping Liu, MD.
    Eur Radiol. 2024 Sep 11. doi: 10.1007/s00330-024-11068.
    >> Share

  95. YU X, Liu H
    Letter to the Editor: "Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection".
    Eur Radiol. 2024 Sep 11. doi: 10.1007/s00330-024-11067.
    >> Share

  96. AZIZI N, Naghibi H, Shakiba M, Morsali M, et al
    Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis.
    Eur Radiol. 2024 Sep 10. doi: 10.1007/s00330-024-11001.
    >> Share

  97. MARRA P, Franchi-Abella S, Hernandez JA, Ronot M, et al
    Percutaneous recanalization of non-cirrhotic extrahepatic portal vein obstruction in children: technical considerations in a preliminary cohort.
    Eur Radiol. 2024 Sep 6. doi: 10.1007/s00330-024-11040.
    >> Share

  98. WANG Y, Qu Y, Yang C, Wu Y, et al
    MRI-based prediction of the need for wide resection margins in patients with single hepatocellular carcinoma.
    Eur Radiol. 2024 Sep 5. doi: 10.1007/s00330-024-11043.
    >> Share

  99. LIN YM, Paolucci I, Albuquerque Marques Silva J, O'Connor CS, et al
    Ablative margin quantification using deformable versus rigid image registration in colorectal liver metastasis thermal ablation: a retrospective single-center study.
    Eur Radiol. 2024;34:5541-5550.
    >> Share

  100. SCHMIDT VF, Ocal O, Walther V, Fabritius MP, et al
    Clinical benefits of MRI-guided freehand biopsy of small focal liver lesions in comparison to CT guidance.
    Eur Radiol. 2024;34:5507-5516.
    >> Share

    August 2024
  101. BARR RG, Ferraioli G
    Letter to the Editor: "Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound".
    Eur Radiol. 2024 Aug 7. doi: 10.1007/s00330-024-10916.
    >> Share

  102. BYENFELDT M
    Reply to Letter to Editor: "Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound".
    Eur Radiol. 2024 Aug 7. doi: 10.1007/s00330-024-10917.
    >> Share

  103. SCIALPI M, Evangelisti A, Shehu K, Comite P, et al
    Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma.
    Eur Radiol. 2024 Aug 2. doi: 10.1007/s00330-024-10925.
    >> Share

  104. CANNELLA R, Zins M, Brancatelli G
    Reply to "Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma".
    Eur Radiol. 2024 Aug 2. doi: 10.1007/s00330-024-10927.
    >> Share

  105. POETTER-LANG S, Ambros R, Messner A, Kristic A, et al
    Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid-enhanced MRI? A large-cohort study.
    Eur Radiol. 2024;34:5215-5227.
    >> Share

  106. GROSS M, Huber S, Arora S, Ze'evi T, et al
    Automated MRI liver segmentation for anatomical segmentation, liver volumetry, and the extraction of radiomics.
    Eur Radiol. 2024;34:5056-5065.
    >> Share

    July 2024
  107. MEYBLUM L, Faron M, Deschamps F, Kobe A, et al
    Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion Chemotherapy.
    Eur Radiol. 2024 Jul 30. doi: 10.1007/s00330-024-10887.
    >> Share

  108. KIM DH, Min EJ, Kim B, Choi JY, et al
    RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab.
    Eur Radiol. 2024 Jul 30. doi: 10.1007/s00330-024-10986.
    >> Share

  109. XU W, Zhang H, Zhang R, Zhong X, et al
    Deep learning model based on contrast-enhanced ultrasound for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma.
    Eur Radiol. 2024 Jul 27. doi: 10.1007/s00330-024-10985.
    >> Share

  110. SOBIREY R, Matuschewski N, Gross M, Lin M, et al
    Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making.
    Eur Radiol. 2024 Jul 20. doi: 10.1007/s00330-024-10955.
    >> Share

  111. PAN J, Huang H, Zhang S, Zhu Y, et al
    Intraindividual comparison of CT and MRI for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma.
    Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10944.
    >> Share

  112. WANG F, Zhang Q, Yan K, Jing X, et al
    3D-CEUS/MRI-CEUS fusion imaging vs 2D-CEUS after locoregional therapies for hepatocellular carcinoma: a multicenter prospective study of therapeutic response evaluation.
    Eur Radiol. 2024 Jul 11. doi: 10.1007/s00330-024-10915.
    >> Share

  113. RONOT M
    Illuminating the shades of hyper- to isointense lesions in hepatobiliary phase imaging.
    Eur Radiol. 2024 Jul 9. doi: 10.1007/s00330-024-10894.
    >> Share

  114. GU K, Jeong WK, Cha DI, Hwang JA, et al
    Bile duct diffusion-weighted image hyperintensity predicts intrahepatic biliary complications after ABO-incompatible liver transplantation.
    Eur Radiol. 2024 Jul 9. doi: 10.1007/s00330-024-10914.
    >> Share

  115. ZOU X, Liu L, Tan F, Tang H, et al
    Non-contrast-enhanced MR angiography of left gastric vein in patients with gastroesophageal varices: morphology and blood supply analysis.
    Eur Radiol. 2024;34:4686-4696.
    >> Share

  116. PEREIRA PL, Siemou P, Rempp HJ, Hoffmann R, et al
    CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
    Eur Radiol. 2024;34:4663-4671.
    >> Share

  117. CAO J, Shon A, Yoon L, Kamaya A, et al
    Diagnostic performance of CT/MRI LI-RADS v2018 in non-cirrhotic steatotic liver disease.
    Eur Radiol. 2024 Jul 1. doi: 10.1007/s00330-024-10846.
    >> Share

    June 2024
  118. FURUMAYA A, Willemssen FEJA, Miclea RL, Haring MPD, et al
    Lesions hyper- to isointense to surrounding liver in the hepatobiliary phase of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2024 Jun 20. doi: 10.1007/s00330-024-10829.
    >> Share

  119. TAGO K, Tsukada J, Sudo N, Shibutani K, et al
    Correction: Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.
    Eur Radiol. 2024 Jun 18. doi: 10.1007/s00330-024-10745.
    >> Share

  120. PICKHARDT PJ, Blake GM, Moeller A, Garrett JW, et al
    Post-contrast CT liver attenuation alone is superior to the liver-spleen difference for identifying moderate hepatic steatosis.
    Eur Radiol. 2024 Jun 4. doi: 10.1007/s00330-024-10816.
    >> Share

  121. VAN DER REIJD DJ, Guerendel C, Staal FCR, Busard MP, et al
    Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
    Eur Radiol. 2024;34:3635-3643.
    >> Share

  122. DUMAN S, Kuru D, Gumussoy M, Kiremitci S, et al
    A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.
    Eur Radiol. 2024;34:3882-3888.
    >> Share

    May 2024
  123. GU K, Min JH, Lee JH, Shin J, et al
    Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection.
    Eur Radiol. 2024 May 20. doi: 10.1007/s00330-024-10780.
    >> Share

  124. CHEN J, Wu Z, Zhang Z, Chen Y, et al
    Apparent diffusion coefficient and tissue stiffness are associated with different tumor microenvironment features of hepatocellular carcinoma.
    Eur Radiol. 2024 May 20. doi: 10.1007/s00330-024-10743.
    >> Share

  125. VOUCHE M
    Large-scale data from real-life practice of percutaneous liver thermal ablation from an international registry: unconditionally trustful Atlas or colossus with feet of clay?
    Eur Radiol. 2024;34:3320-3321.
    >> Share

  126. ZENSEN S, Bucker A, Meetschen M, Haubold J, et al
    Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.
    Eur Radiol. 2024;34:3322-3330.
    >> Share

  127. MENDIRATTA-LALA M, Aslam A, Bai HX, Chapiro J, et al
    Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.
    Eur Radiol. 2024;34:3284-3297.
    >> Share

  128. LEWIN M
    Can HCC postresection survival be predicted with prognostic MRI features?
    Eur Radiol. 2024;34:3160-3162.
    >> Share

    April 2024
  129. RATA M, De Paepe KN, Orton MR, Castagnoli F, et al
    Evaluation of simultaneous multi-slice acquisition with advanced processing for free-breathing diffusion-weighted imaging in patients with liver metastasis.
    Eur Radiol. 2024;34:2457-2467.
    >> Share

  130. CARUSO D, De Santis D, Del Gaudio A, Guido G, et al
    Low-dose liver CT: image quality and diagnostic accuracy of deep learning image reconstruction algorithm.
    Eur Radiol. 2024;34:2384-2393.
    >> Share

  131. NAKAZAWA Y, Okada M, Hyodo T, Tago K, et al
    Comparison between CT volumetry, technetium(99m) galactosyl-serum-albumin scintigraphy, and gadoxetic-acid-enhanced MRI to estimate the liver fibrosis stage in preoperative patients.
    Eur Radiol. 2024;34:2212-2222.
    >> Share

    March 2024
  132. GROSS M, Haider SP, Ze'evi T, Huber S, et al
    Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning.
    Eur Radiol. 2024 Mar 27. doi: 10.1007/s00330-024-10624.
    >> Share

  133. KIM TH, Woo S, Lee DH, Do RK, et al
    MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis.
    Eur Radiol. 2024 Mar 20. doi: 10.1007/s00330-024-10671.
    >> Share

  134. BOUATTOUR M, Vilgrain V, Sepulveda A
    ESR Bridges: imaging and treatment of hepatocellular carcinoma-a multidisciplinary view.
    Eur Radiol. 2024 Mar 15. doi: 10.1007/s00330-023-10579.
    >> Share

  135. BYENFELDT M, Kihlberg J, Nasr P, Gronlund C, et al
    Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound.
    Eur Radiol. 2024 Mar 8. doi: 10.1007/s00330-024-10655.
    >> Share

  136. ZHANG A, Meng X, Yao Y, Zhou X, et al
    Head to head comparison of (68)Ga-DOTA-FAPI-04 vs (18)F-FDG PET/CT in the evaluation of primary extrapulmonary tumors in the chest.
    Eur Radiol. 2024;34:1960-1970.
    >> Share

    February 2024
  137. YOO J, Joo I, Jeon SK, Park J, et al
    Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters.
    Eur Radiol. 2024 Feb 23. doi: 10.1007/s00330-024-10660.
    >> Share

  138. CANNELLA R, Zins M, Brancatelli G
    ESR Essentials: diagnosis of hepatocellular carcinoma-practice recommendations by ESGAR.
    Eur Radiol. 2024 Feb 21. doi: 10.1007/s00330-024-10606.
    >> Share

  139. VARIN E, Beunon P, N'Kontchou G, Petit A, et al
    Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinoma.
    Eur Radiol. 2024 Feb 9. doi: 10.1007/s00330-024-10617.
    >> Share

  140. KIM GH, Kim JH, Shim JH, Kim SY, et al
    Chemoembolization versus radiofrequency ablation for single small (
    Eur Radiol. 2024 Feb 8. doi: 10.1007/s00330-024-10634.
    >> Share

  141. ZHANG Y, Hu X, Chang J, Li W, et al
    A new method to estimate the histological stage of primary biliary cholangitis.
    Eur Radiol. 2024;34:770-779.
    >> Share

  142. ZHANG Y, Fan X, Song B, Liu Y, et al
    Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI.
    Eur Radiol. 2024;34:1268-1279.
    >> Share

    January 2024
  143. LIU W, Wei R, Chen J, Li Y, et al
    Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning.
    Eur Radiol. 2024 Jan 30. doi: 10.1007/s00330-024-10581.
    >> Share

  144. XU Y, Yang Y, Ouyang J, Zhou Y, et al
    Publisher Correction: Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
    Eur Radiol. 2024 Jan 29. doi: 10.1007/s00330-023-10575.
    >> Share

  145. AUER TA
    Diffusion-weighted imaging for the detection of liver metastases in the preoperative evaluation of pancreatic cancer - are we really at the end of the road?
    Eur Radiol. 2024;34:103-105.
    >> Share

  146. ALTMAYER S, Armelin LM, Pereira JS, Carvalho LV, et al
    MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis.
    Eur Radiol. 2024;34:106-114.
    >> Share

  147. QIN S, Chen Y, Wang Y, Li F, et al
    Contrast-enhanced ultrasound with microbubbles containing sulfur hexafluoride and perfluorobutane with Kupffer phase for the detection of colorectal liver metastases.
    Eur Radiol. 2024;34:622-631.
    >> Share

  148. CUI E
    Reducing radiation dose in routine CT scans: an AI-driven approach with deep learning-based dual-energy CT reconstruction.
    Eur Radiol. 2024;34:26-27.
    >> Share

  149. LYU P, Li Z, Chen Y, Wang H, et al
    Deep learning reconstruction CT for liver metastases: low-dose dual-energy vs standard-dose single-energy.
    Eur Radiol. 2024;34:28-38.
    >> Share

  150. MIN JH, Lee MW, Rhim H, Han S, et al
    LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
    Eur Radiol. 2024;34:525-537.
    >> Share

    December 2023
  151. TAOULI B, Ba-Ssalamah A, Chapiro J, Chhatwal J, et al
    Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.
    Eur Radiol. 2023;33:9152-9166.
    >> Share

  152. JOSKOWICZ L, Szeskin A, Rochman S, Dodi A, et al
    Follow-up of liver metastases: a comparison of deep learning and RECIST 1.1.
    Eur Radiol. 2023;33:9320-9327.
    >> Share

  153. TAOULI B, Ba-Ssalamah A, Chapiro J, Chhatwal J, et al
    Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
    Eur Radiol. 2023;33:9167-9181.
    >> Share

  154. HUANG H, Li CQ, He DN, Ruan SM, et al
    Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound.
    Eur Radiol. 2023;33:9336-9346.
    >> Share

  155. ORCEL T, Chau HT, Turlin B, Chaigneau J, et al
    Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
    Eur Radiol. 2023;33:8999-9009.
    >> Share

  156. JIN ZC, Zhong BY, Chen JJ, Zhu HD, et al
    Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.
    Eur Radiol. 2023;33:8669-8681.
    >> Share

  157. ZHANG K, Zhang L, Li WC, Xie SS, et al
    Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
    Eur Radiol. 2023;33:8936-8947.
    >> Share

    November 2023
  158. DUCATEL A, Trillaud H, Reizine E, Vilgrain V, et al
    Sonic hedgehog hepatocellular adenoma: magnetic resonance imaging features and correlation with histology.
    Eur Radiol. 2023 Nov 28. doi: 10.1007/s00330-023-10344.
    >> Share

  159. YAN H, Xiang Z, Zhao C, Luo S, et al
    6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding.
    Eur Radiol. 2023 Nov 25. doi: 10.1007/s00330-023-10346.
    >> Share

  160. REN J, Lu Q, Fei X, Dong Y, et al
    Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue(R) and Sonazoid(R).
    Eur Radiol. 2023 Nov 22. doi: 10.1007/s00330-023-10371.
    >> Share

  161. DEMONDION E, Ernst O, Louvet A, Robert B, et al
    Hepatic fat quantification in dual-layer computed tomography using a three-material decomposition algorithm.
    Eur Radiol. 2023 Nov 13. doi: 10.1007/s00330-023-10382.
    >> Share

  162. BASTATI N, Perkonigg M, Sobotka D, Poetter-Lang S, et al
    Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.
    Eur Radiol. 2023;33:7729-7743.
    >> Share

  163. CANNELLA R, Santinha J, Beaufrere A, Ronot M, et al
    Performances and variability of CT radiomics for the prediction of microvascular invasion and survival in patients with HCC: a matter of chance or standardisation?
    Eur Radiol. 2023;33:7618-7628.
    >> Share

  164. CHEN X, Hu P, Yu H, Tan H, et al
    Head-to-head intra-individual comparison of total-body 2-[(18)F]FDG PET/CT and digital PET/CT in patients with malignant tumor: how sensitive could it be?
    Eur Radiol. 2023;33:7890-7898.
    >> Share

  165. FERRAIOLI G
    Diffuse liver disease: the new horizon of multiparametric ultrasound.
    Eur Radiol. 2023;33:7629-7630.
    >> Share

  166. LEBLANC M, Kang J, Costa AF
    Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false negatives.
    Eur Radiol. 2023;33:7656-7664.
    >> Share

  167. PALMISANO A, Gnasso C, Cereda A, Vignale D, et al
    Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study.
    Eur Radiol. 2023;33:7756-7768.
    >> Share

    October 2023
  168. YU H, Zhao F, Men X, Zhu H, et al
    Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
    Eur Radiol. 2023 Oct 25. doi: 10.1007/s00330-023-10268.
    >> Share

  169. HWANG SH, Rhee H
    Pushing the limit of hepatocellular carcinoma diagnosis: diagnosis of subcentimetre HCC using gadoxetic acid-enhanced MRI and alpha-fetoprotein.
    Eur Radiol. 2023 Oct 23. doi: 10.1007/s00330-023-10376.
    >> Share

  170. JIANG H, Qin Y, Wei H, Zheng T, et al
    Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma.
    Eur Radiol. 2023 Oct 23. doi: 10.1007/s00330-023-10279.
    >> Share

  171. ZHANG Y, Chen J, Yang C, Dai Y, et al
    Preoperative prediction of microvascular invasion in hepatocellular carcinoma using diffusion-weighted imaging-based habitat imaging.
    Eur Radiol. 2023 Oct 19. doi: 10.1007/s00330-023-10339.
    >> Share

  172. HEO S, Kang HJ, Choi SH, Kim S, et al
    Proliferative hepatocellular carcinomas in cirrhosis: patient outcomes of LI-RADS category 4/5 and category M.
    Eur Radiol. 2023 Oct 18. doi: 10.1007/s00330-023-10305.
    >> Share

  173. DELAGNES A, Roux M, Vilgrain V, Guiu B, et al
    Fat-containing hepatocellular carcinoma in patients with cirrhosis: proposal of a diagnostic modification regarding enhancement characteristics.
    Eur Radiol. 2023 Oct 11. doi: 10.1007/s00330-023-10236.
    >> Share

  174. YU Q, Ungchusri E, Pillai A, Liao CY, et al
    Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
    Eur Radiol. 2023 Oct 9. doi: 10.1007/s00330-023-10203.
    >> Share

  175. HUANG P, Wu F, Hou K, Zhou C, et al
    Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2023 Oct 4. doi: 10.1007/s00330-023-10214.
    >> Share

  176. HERNANDO D, van der Heijden RA, Reeder SB
    A better understanding of liver T1.
    Eur Radiol. 2023;33:6841-6843.
    >> Share

  177. HIGASHI M, Tanabe M, Yamane M, Keerthivasan MB, et al
    Impact of fat on the apparent T1 value of the liver: assessment by water-only derived T1 mapping.
    Eur Radiol. 2023;33:6844-6851.
    >> Share

  178. AMORIM J
    HCC screening with non-contrast MRI and alpha-fetoprotein: combining a new player with an old friend.
    Eur Radiol. 2023;33:6927-6928.
    >> Share

  179. WARY P, Hossu G, Ambarki K, Nickel D, et al
    Deep learning HASTE sequence compared with T2-weighted BLADE sequence for liver MRI at 3 Tesla: a qualitative and quantitative prospective study.
    Eur Radiol. 2023;33:6817-6827.
    >> Share

  180. RADIYA K, Joakimsen HL, Mikalsen KO, Aahlin EK, et al
    Performance and clinical applicability of machine learning in liver computed tomography imaging: a systematic review.
    Eur Radiol. 2023;33:6689-6717.
    >> Share

  181. AUER TA, Halskov S, Fehrenbach U, Nevermann NF, et al
    Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5(th) edition of the World Health Organization classification.
    Eur Radiol. 2023;33:6902-6915.
    >> Share

  182. VOLPE S, Mastroleo F, Krengli M, Jereczek-Fossa BA, et al
    Quo vadis Radiomics? Bibliometric analysis of 10-year Radiomics journey.
    Eur Radiol. 2023;33:6736-6745.
    >> Share

  183. PARK HL, Boo SH, Park SY, Moon SW, et al
    Prognostic value of TLR from FDG PET/CT in patients with margin-negative stage IB and IIA non-small cell lung cancer.
    Eur Radiol. 2023;33:7274-7283.
    >> Share

    September 2023
  184. ZAFAR S, Elbanna KY, Todd AWM, Guimaraes L, et al
    Can absolute arterial phase hyperenhancement improve sensitivity of detection of hepatocellular carcinoma in indeterminate nodules on CT?
    Eur Radiol. 2023 Sep 30. doi: 10.1007/s00330-023-10237.
    >> Share

  185. XU Y, Yang Y, Ouyang J, Zhou Y, et al
    Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
    Eur Radiol. 2023 Sep 23. doi: 10.1007/s00330-023-10222.
    >> Share

  186. YOON S, Shim YS, Park SH, Sung J, et al
    Hepatobiliary phase imaging in cirrhotic patients using compressed sensing and controlled aliasing in parallel imaging results in higher acceleration.
    Eur Radiol. 2023 Sep 21. doi: 10.1007/s00330-023-10226.
    >> Share

  187. DING F, Huang M, Ren P, Zhang J, et al
    Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study.
    Eur Radiol. 2023 Sep 11. doi: 10.1007/s00330-023-10227.
    >> Share

  188. NACHIT M, Dioguardi Burgio M, Abyzov A, Garteiser P, et al
    Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles.
    Eur Radiol. 2023 Sep 2. doi: 10.1007/s00330-023-10131.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016